175 related articles for article (PubMed ID: 36789593)
1. [Clinical features and long-term prognosis of diabetic patients with low or intermediate complexity coronary artery disease post percutaneous coronary intervention].
Chen Y; Zhu P; Xu JJ; Song Y; Jiang L; Gao LJ; Chen J; Song L; Gao Z; Liu HB; Yang YJ; Gao RL; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Feb; 51(2):143-150. PubMed ID: 36789593
[No Abstract] [Full Text] [Related]
2. [Outcome of patients with coronary artery disease and left ventricular ejection fraction less than 50% undergoing percutaneous coronary intervention].
Jiang L; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Gao LJ; Song L; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1058-1066. PubMed ID: 29325366
[No Abstract] [Full Text] [Related]
3. [Predictive value of SYNTAX-Ⅱ score on prognosis of patients with chronic total occlusion undergoing percutaneous coronary intervention].
Wang J; Xu HB; Qiao SB; Guan FH; Hu WX; Yang JS; Yuan JG; Cui L; Song M; Zhang P; Xu B
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Dec; 50(12):1186-1192. PubMed ID: 36517439
[No Abstract] [Full Text] [Related]
4. [Clinical characteristics and prognosis between male and female patients with premature coronary artery disease after intervention].
Tang XF; Song Y; Xu JJ; Wang HH; Jiang L; Jiang P; Yao Y; Zhao XY; Gao Z; Yang YJ; Qiao SB; Gao RL; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Oct; 47(10):798-805. PubMed ID: 31648462
[No Abstract] [Full Text] [Related]
5. [Impact of short-time anticoagulant therapy after selective percutaneous intervention on prognosis of patients with coronary artery disease].
Song Y; Tang XF; Xu JJ; Wang HH; Liu R; Jiang P; Jiang L; Gao LJ; Zhang Y; Song L; Xu LJ; Zhao XY; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):108-116. PubMed ID: 30818938
[No Abstract] [Full Text] [Related]
6. [Relationship between thrombolysis in myocardial infarction risk index and the severity of coronary artery lesions and long-term outcome in acute myocardial infarction patients undergoing percutaneous coronary intervention].
Chen Y; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Jiang L; Liu R; Zhao XY; Gao LJ; Song L; Zhang Y; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Nov; 46(11):874-881. PubMed ID: 30462976
[No Abstract] [Full Text] [Related]
7. Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention.
Di Maio M; Esposito L; Silverio A; Bellino M; Cancro FP; De Luca G; Di Muro FM; Vassallo MG; Vecchione C; Galasso G
Catheter Cardiovasc Interv; 2023 Nov; 102(5):779-787. PubMed ID: 37702117
[TBL] [Abstract][Full Text] [Related]
8. Impact of residual coronary lesions on outcomes of myocardial infarction patients with multi-vessel disease.
Ahmed TAN; Othman AAA; Demitry SR; Elmaghraby KM
BMC Cardiovasc Disord; 2024 Jan; 24(1):68. PubMed ID: 38262995
[TBL] [Abstract][Full Text] [Related]
9. The impact of coronary artery disease severity on long-term outcomes in unprotected left main coronary artery revascularization.
Kahraman S; Zencirkiran Agus H; Demirci G; Can C; Demir AR; Güner A; Kalkan AK; Uzun F; Ertürk M; Yıldız M
Turk Kardiyol Dern Ars; 2021 Jan; 49(1):8-21. PubMed ID: 33390575
[TBL] [Abstract][Full Text] [Related]
10. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
[TBL] [Abstract][Full Text] [Related]
11. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients.
Contini GA; Nicolini F; Fortuna D; Pacini D; Gabbieri D; Vignali L; Valgimigli M; Manari A; Zussa C; Guastaroba P; De Palma R; Grilli R; Gherli T
Int J Cardiol; 2013 Sep; 168(2):1028-33. PubMed ID: 23164591
[TBL] [Abstract][Full Text] [Related]
12. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.
Sun LY; Gaudino M; Chen RJ; Bader Eddeen A; Ruel M
JAMA Cardiol; 2020 Jun; 5(6):631-641. PubMed ID: 32267465
[TBL] [Abstract][Full Text] [Related]
13. [Outcome analysis of patients undergoing percutaneous coronary intervention with or without prior coronary artery bypass grafting operation].
Song Y; Xu JJ; Tang XF; Wang HH; Liu R; Jiang P; Jiang L; Gao LJ; Zhang Y; Song L; Xu LJ; Zhao XY; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jul; 45(7):559-565. PubMed ID: 28738483
[No Abstract] [Full Text] [Related]
14. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Effect of the SYNTAX Score on 10-Year Outcomes After Left Main Coronary Artery Revascularization in a Randomized Population: Insights From the Extended PRECOMBAT Trial.
Lee J; Ahn JM; Kim JH; Jeong YJ; Hyun J; Yang Y; Lee JS; Park H; Kang DY; Lee PH; Park DW; Park SJ;
J Am Heart Assoc; 2021 Jul; 10(14):e020359. PubMed ID: 34227392
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy comparison of 3 strategies for real-world stable coronary artery disease patients with three-vessel disease].
Liu R; Jiang L; Xu LJ; Tian J; Zhao XY; Zhang Y; Xu JJ; Song Y; Wang HH; Gao Z; Song L; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1049-1057. PubMed ID: 29325365
[No Abstract] [Full Text] [Related]
17. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of SYNTAX score on 1 year outcome in patients underwent percutaneous coronary intervention].
Wang J; Guan CD; Yuan JS; Gao RL; Xu B; Qiao SB
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Apr; 46(4):267-273. PubMed ID: 29747321
[No Abstract] [Full Text] [Related]
19. [Association between plasma HDL-C levels and coronary artery severity and impact on outcomes of patients underwent percutaneous coronary intervention].
Song Y; Jiang L; Chen Y; Song L; Zhang Y; Gao LJ; Xu LJ; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Feb; 48(2):123-129. PubMed ID: 32135612
[No Abstract] [Full Text] [Related]
20. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
